ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
1 Year Est. Return
+7.38%
AUM
$111M
AUM Growth
+$33.8M
(+44%)
Holding
58
Top Buys
| 1 | +$12.1M | |
| 2 | +$7.38M | |
| 3 | +$6.46M | |
| 4 |
Avantor
AVTR
|
+$4.83M |
| 5 |
CONMED
CNMD
|
+$4.82M |
Top Sells
| 1 | +$7.86M | |
| 2 | +$5.63M | |
| 3 | +$5.5M | |
| 4 |
Becton Dickinson
BDX
|
+$3.53M |
| 5 |
IQVIA
IQV
|
+$3.31M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Real Estate | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Masimo
MASI
$9.19B
| – | – |
-2,850
|
|
||
52
Medtronic
MDT
$112B
| – | – |
-27,181
|
|
||
53
Qiagen
QGEN
$8.34B
| – | – |
-59,137
|
|
||
54
Viking Therapeutics
VKTX
$3.88B
| – | – |
-20,754
|
|
||
55
Ventas
VTR
$41.5B
| – | – |
-41,575
|
|
||
56
Zoetis
ZTS
$49.5B
| – | – |
-7,643
|
|
||
57
State Street SPDR S&P 500 ETF Trust
SPY
$661B
| – | – |
0
|
|
||
58
Teva Pharmaceuticals
TEVA
$34.5B
| – | – |
0
|
|